CARA logo

Cara Therapeutics (CARA) Accounts Payable

Annual Accounts Payable

$11.58 M
+$1.98 M+20.61%

December 31, 2023


Summary


Performance

CARA Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCARAbalance sheetmetrics:

Quarterly Accounts Payable

$2.54 M
-$4.21 M-62.38%

September 30, 2024


Summary


Performance

CARA Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCARAbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

CARA Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.6%0.0%
3 y3 years+136.7%0.0%
5 y5 years+165.0%0.0%

CARA Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+105.9%-83.3%at low
5 y5-yearat high+136.7%-83.3%at low
alltimeall timeat high+2354.0%-83.3%+438.4%

Cara Therapeutics Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$2.54 M(-62.4%)
Jun 2024
-
$6.75 M(+35.7%)
Mar 2024
-
$4.98 M(-57.0%)
Dec 2023
$11.58 M(+20.6%)
$11.58 M(+45.2%)
Sep 2023
-
$7.98 M(-34.2%)
Jun 2023
-
$12.12 M(+174.0%)
Mar 2023
-
$4.42 M(-53.9%)
Dec 2022
$9.60 M(+70.7%)
$9.60 M(-36.9%)
Sep 2022
-
$15.22 M(+56.2%)
Jun 2022
-
$9.74 M(+74.1%)
Mar 2022
-
$5.59 M(-0.6%)
Dec 2021
$5.63 M(+15.0%)
$5.63 M(+4.8%)
Sep 2021
-
$5.37 M(+58.6%)
Jun 2021
-
$3.39 M(-28.9%)
Mar 2021
-
$4.76 M(-2.6%)
Dec 2020
$4.89 M(-46.2%)
$4.89 M(-24.5%)
Sep 2020
-
$6.48 M(+34.3%)
Jun 2020
-
$4.83 M(-48.1%)
Mar 2020
-
$9.31 M(+2.3%)
Dec 2019
$9.10 M(+108.2%)
$9.10 M(-4.6%)
Sep 2019
-
$9.54 M(+283.7%)
Jun 2019
-
$2.48 M(-49.7%)
Mar 2019
-
$4.94 M(+13.1%)
DateAnnualQuarterly
Dec 2018
$4.37 M(+14.2%)
$4.37 M(+65.7%)
Sep 2018
-
$2.64 M(-28.5%)
Jun 2018
-
$3.69 M(+219.4%)
Mar 2018
-
$1.16 M(-69.8%)
Dec 2017
$3.83 M(-19.2%)
$3.83 M(+222.6%)
Sep 2017
-
$1.19 M(-36.4%)
Jun 2017
-
$1.86 M(+10.5%)
Mar 2017
-
$1.69 M(-64.4%)
Dec 2016
$4.74 M(+141.1%)
$4.74 M(+98.5%)
Sep 2016
-
$2.39 M(-18.6%)
Jun 2016
-
$2.93 M(+24.8%)
Mar 2016
-
$2.35 M(+19.5%)
Dec 2015
$1.97 M(+281.6%)
$1.97 M(+55.6%)
Sep 2015
-
$1.26 M(+77.6%)
Jun 2015
-
$711.00 K(-24.2%)
Mar 2015
-
$938.00 K(+82.1%)
Dec 2014
$515.00 K(-23.8%)
$515.00 K(-70.0%)
Sep 2014
-
$1.72 M(+44.0%)
Jun 2014
-
$1.19 M(-24.9%)
Mar 2014
-
$1.59 M(+134.6%)
Dec 2013
$676.00 K(+43.2%)
$676.00 K(-47.5%)
Sep 2013
-
$1.29 M(+172.9%)
Dec 2012
$472.00 K(-27.5%)
$472.00 K
Dec 2011
$651.00 K
-

FAQ

  • What is Cara Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Cara Therapeutics?
  • What is Cara Therapeutics annual accounts payable year-on-year change?
  • What is Cara Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Cara Therapeutics?
  • What is Cara Therapeutics quarterly accounts payable year-on-year change?

What is Cara Therapeutics annual accounts payable?

The current annual accounts payable of CARA is $11.58 M

What is the all time high annual accounts payable for Cara Therapeutics?

Cara Therapeutics all-time high annual accounts payable is $11.58 M

What is Cara Therapeutics annual accounts payable year-on-year change?

Over the past year, CARA annual accounts payable has changed by +$1.98 M (+20.61%)

What is Cara Therapeutics quarterly accounts payable?

The current quarterly accounts payable of CARA is $2.54 M

What is the all time high quarterly accounts payable for Cara Therapeutics?

Cara Therapeutics all-time high quarterly accounts payable is $15.22 M

What is Cara Therapeutics quarterly accounts payable year-on-year change?

Over the past year, CARA quarterly accounts payable has changed by $0.00 (0.00%)